Association of remnant cholesterol with frailty: findings from observational and Mendelian randomization analyses
Authors:
Open Access
- 3 August 2023
- journal article
- research article
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 22 (1) , 1-12
Abstract
Background: Recent insights suggest that remnant cholesterol (RC) plays a role in cellular senescence, yet its specific contribution to frailty remains indeterminate. Through the integration of observational and mendelian randomization (MR) studies, this research explores the impact of elevated serum RC levels on frailty susceptibility. Methods: A dual-method approach, combining an observational study with an MR study, was employed to investigate the connection between RC and frailty. The observational study included 11,838 participants from the National Health and Nutrition Examination Survey. Multivariable logistic regression and propensity score matching were employed to control for potential confounders. The non-linear relationship was assessed using restricted cubic splines. To circumvent observational study limitations, a two-sample MR analysis was conducted using the inverse-variance weighted method, leveraging genome-wide association studies (GWAS) data. Results: After adjusting for potential confounding variables, the observational study identified a significant association between high serum RC levels and frailty in middle-aged and older adults (odds ratio [OR] = 1.67, 95% confidence interval [CI] = 1.20 to 2.33, P = 0.003), exhibiting a non-linear dose–response correlation (non-linear P = 0.011). This association persisted after propensity score matching (OR = 1.53, 95% CI = 1.14 to 2.06, P = 0.005). The MR study echoed these results, demonstrating a causal association of RC with the frailty index (β = 0.059, 95% CI = 0.033 to 0.085, P = 1.05E-05), consistent with the observational findings (β = 0.017, 95% CI = 0.008 to 0.026, P = 4.51E-04). Conclusion: This study provides evidence that higher RC levels amplify frailty risk in middle-aged and older adults, implying that the reduction of RC levels may present a promising strategy for frailty prevention and management.Keywords
Funding Information
- National Natural Science Foundation of China (81974566)
This publication has 43 references indexed in Scilit:
- Development and validation of an electronic frailty index using routine primary care electronic health record dataAge and Ageing, 2016
- Frailty in NHANES: Comparing the frailty index and phenotypeArchives of Gerontology and Geriatrics, 2015
- Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatmentPharmacology & Therapeutics, 2014
- Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid ProfileJAMA, 2013
- The frailty phenotype and the frailty index: different instruments for different purposesAge and Ageing, 2013
- Avoiding bias from weak instruments in Mendelian randomization studiesInternational Journal of Epidemiology, 2011
- Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variantsInternational Journal of Epidemiology, 2010
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009
- A standard procedure for creating a frailty indexBMC Geriatrics, 2008
- A Comparison of Two Approaches to Measuring Frailty in Elderly PeopleThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2007